Related Experiment Videos
Stimulation of interleukin-6 production by corticotropin-releasing factor
Insights
Corticotropin-releasing factor (CRF) significantly boosts interleukin-6 (IL-6) production in human immune cells. This neurohormone may play a key role in regulating the neuroendocrine-immune system.
Area of Science:
- Neuroendocrinology
- Immunology
- Cellular Biology
Background:
- Corticotropin-releasing factor (CRF) is known for its immune-modulating properties.
- Interleukin-6 (IL-6) is a key cytokine involved in immune responses.
Purpose of the Study:
- To investigate the effect of CRF on interleukin-6 (IL-6) production in human peripheral blood mononuclear cells (MNC).
Main Methods:
- Human peripheral blood mononuclear cells (MNC) were cultured and treated with varying concentrations of CRF.
- IL-6 production was measured using bioassays.
- Specific cell types (monocytes and lymphocytes) were purified to determine responsiveness.
Main Results:
- CRF significantly increased bioactive IL-6 production by MNC in a dose-dependent manner (10⁻¹⁰ to 10⁻⁷ M).
- CRF did not affect IL-6 production in lipopolysaccharide-stimulated MNC cultures.
- CRF and its analogs (Tyr-CRF, alpha-helical CRF) stimulated IL-6 production 16- to 21-fold at concentrations ≥10 nM.
- Purified monocytes, but not lymphocytes, were responsive to CRF, showing a 19-fold increase at 100 nM.
Conclusions:
- CRF stimulates IL-6 production in human monocytes, suggesting a role in immune modulation.
- CRF may act as a messenger in the neuroendocrine-immune feedback loop.
- These findings highlight the intricate connection between the neuroendocrine and immune systems.
Abstract:
Based on the immune-modulating properties of corticotropin-releasing factor (CRF), the effect of this peptide for interleukin-6 (IL-6) production was investigated. Using human peripheral blood mononuclear cells (MNC), the amount of bioactive IL-6 produced was significantly (P less than or equal to 0.05) increased by CRF (10(-10) to 10(-7) M range). However, the IL-6 production of lipopolysaccharide-treated MNC cultures was not modified. At concentrations of greater than or equal to 10 nM, CRF and two analogous peptides (Tyr-CRF and alpha-helical CRF) elicited 16- to 21-fold stimulation of IL-6 production by MNC. Purified monocytes, but not purified lymphocytes, were the cells that responded to CRF action exhibiting nearly 19-fold stimulation at 100 nM concentration. The CRF-induced production of IL-6 cytokine by peripheral blood MNC may suggest a messenger role for this neurohormone in the feedback control of neuroendocrine-immune circuitry.